Midas Pharma Polska Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Midas Pharma Polska Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Wholesale Trade Agents and Brokers sector. It was established on August 03, 2005. It currently has a total number of 101 - 250 (2013) employees. From the latest financial highlights, Midas Pharma Polska Sp. z o.o. reported a net sales revenue increase of 11.2% in 2022. Its total assets grew by 30.32% over the same period. The net profit margin of Midas Pharma Polska Sp. z o.o. increased by 1.05% in 2022.

Headquarters
Ul. Hankiewicza 2
Warsaw; Mazowieckie; Postal Code: 02-103

Contact Details: Purchase the Midas Pharma Polska Sp. z o.o. report to view the information.

Website: http://www.midaspharma.com

Basic Information

Total Employees:

Purchase the Midas Pharma Polska Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Midas Pharma Polska Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Midas Pharma Polska Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Midas Pharma Polska Sp. z o.o. report to view the information.

Incorporation Date:

August 03, 2005

Key Executives

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

99.9%

Company Performance

Financial values in the chart are available after Midas Pharma Polska Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

11.2%▲

Total operating revenue

11.16%▲

Operating profit (EBIT)

27.95%▲

EBITDA

27.16%▲

Net Profit (Loss) for the Period

33.82%▲

Total assets

30.32%▲

Total equity

44.97%▲

Operating Profit Margin (ROS)

0.87%▲

Net Profit Margin

1.05%▲

Return on Equity (ROE)

-2.58%▼

Debt to Equity Ratio

-0.98%▼

Quick Ratio

0.36%▲

Cash Ratio

0.17%▲

Midas Pharma Polska Sp. z o.o. (Poland)